- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00516178
Intravenous Fish Oil in Critically Ill Cardiac Patients (FO-cardiac)
Effects of Intravenous n-3 Polyunsaturated Fatty Acid Administration in Critically Ill Cardiac Surgery and Myocardial Infarction Patients
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
A. Randomized trial in 40 cardiac surgery patients Early rapid infusion of fish oil (3 times in 24 hours) in cardiac surgery patients.
B. Randomized trial 20 myocardial infarction patients (abandonned) Continuous infusion of the same dose over 24hrs in the myocardial infarction patients
Additional trial in healthy volunteers (investigating physiological changes after cardiac study):
-Open trial in 8 healthy lean volunteers to investigate the impact of the same 0.6 g/kg FO dose IV (Week 1: 3hrs), and then orally on week 2, on platelet n-3 PUFA incorporation, platelet function, heart rate and peak flow response to stress test.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Fase 3
Kontakter og lokationer
Studiesteder
-
-
VD
-
Lausanne, VD, Schweiz, 1011
- Service of Adult Intensive Care - CHUV
-
Lausanne, VD, Schweiz, 1011
- CHUV
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Coronary artery disease requiring elective surgical repair under cardiopulmonary bypass
- Acute myocardial infarction requiring ICU management
Exclusion Criteria:
- Absence of consent
- Ventricular ejection fraction < 35%
- Beating heart surgery or emergency surgery
- Hypercholesterolemia > 5 mmol/l
- Thrombolysis
- Chronic steroid therapy
- Acute or chronic renal failure prior to surgery (plasma creatinine > 150 umol/l)
- Chronic coagulation disorder
- Premenopausal female
- Consumption of more than 3 times fish per week
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Tredobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Placebo komparator: Placebo
Saline (No lipid emulsion)
|
3 infusions, perioperative or post-PTCA
|
Eksperimentel: Fish oil emulsion
3 infusions of 0.2 g/kg omega-3 PUFA within 24 hours in cardiac surgery (continuous infusion post-PTCA)
|
0.2 g/kg FO, 3 times in 24 hours, infused over 3 hours each in cardiac surgery, or continuous infusion of 0.6 g/kg post PTCA
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Incorporation of n-3 PUFA into platelet cell membrane and myocardial tissue
Tidsramme: 48 hours
|
The primary outcome is the determination of magnitude of the incorporation and the time required for incorporation of omega-3 fatty acid cell membrane composition after short intravenous infusions was unknown until the present study (HPLC determination of fatty acid membrane composition in all patients)
|
48 hours
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Inflammatory and metabolic response
Tidsramme: From operation to ICU discharge (maximum 28 days)
|
cytokine determination, CRP, glucose control (blood levels and insulin requirements) in all patients
|
From operation to ICU discharge (maximum 28 days)
|
Global clinical outcome
Tidsramme: From operation to hospital discharge (maximum 28 days)
|
length of mechanical ventilation, length of ICU and hospital stay in all patients
|
From operation to hospital discharge (maximum 28 days)
|
Myocardial recovery after surgery
Tidsramme: From operation to hospital discharge (maximum 28 days)
|
Holter monitoring during cardiac surgery or for 72 hours
|
From operation to hospital discharge (maximum 28 days)
|
Samarbejdspartnere og efterforskere
Efterforskere
- Studieleder: Mette M Berger, MD, PhD, Serviceof Adult Intensive Care, CHUV
Publikationer og nyttige links
Generelle publikationer
- Berger MM, Delodder F, Liaudet L, Tozzi P, Schlaepfer J, Chiolero RL, Tappy L. Three short perioperative infusions of n-3 PUFAs reduce systemic inflammation induced by cardiopulmonary bypass surgery: a randomized controlled trial. Am J Clin Nutr. 2013 Feb;97(2):246-54. doi: 10.3945/ajcn.112.046573. Epub 2012 Dec 26.
- Delodder F, Tappy L, Liaudet L, Schneiter P, Perrudet C, Berger MM. Incorporation and washout of n-3 PUFA after high dose intravenous and oral supplementation in healthy volunteers. Clin Nutr. 2015 Jun;34(3):400-8. doi: 10.1016/j.clnu.2014.07.005. Epub 2014 Jul 15.
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- FN-3200BO-102064
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Koronararteriesygdom
-
IRCCS Policlinico S. DonatoRekrutteringAnomalous aorta origin of the coronary artery (AAOCA)Italien
-
University Hospital OstravaRekrutteringIn-Stent Carotis Artery RestenosisTjekkiet
-
Sohag UniversityIkke rekrutterer endnuUmblical artery Doppler under terminsgraviditetEgypten
-
Inova Health Care ServicesBoston Scientific CorporationAfsluttetKoronar angiografi | Transradial adgang | Radial arterie Intimal Medial Tykkelse | Distal Radial Artery Access (dTRA)Forenede Stater
-
Baylor College of MedicineAfsluttetLungeblødning | MAPCA - Major Aortopulmonary Collateral ArteryForenede Stater
-
Daewoong Pharmaceutical Co. LTD.UkendtMCA - Middle Cerebral Artery DissektionKorea, Republikken
-
Resicardunion nationale de formation et d'evaluation en medecine cardio-vasculaireAfsluttetHjertefejl | Akut koronarsyndrom | Koronar bypass-graft Stenose af Native Artery GraftFrankrig
-
AldagenUkendtSlag | Iskæmisk slagtilfælde | Slagtilfælde i Middle Cerebral Artery (MCA)Forenede Stater
Kliniske forsøg med Saline
-
Saglik Bilimleri Universitesi Gulhane Tip FakultesiAfsluttetOral mucositis | Hoved- og halskræftKalkun
-
TC Erciyes UniversityAfsluttet
-
Tanta UniversityRekrutteringDexmedetomidin neurobeskyttende effekt ved traumatisk hjerneskadeEgypten